Cancer survivors’ self-efficacy to self-manage in the year following primary treatment
PURPOSE Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficac...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Springer
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/32446/ |
| _version_ | 1848794408607023104 |
|---|---|
| author | Foster, Claire Breckons, Matthew Cotterell, P. Barbosa, D. Calman, Lynn Corner, Jessica Fenlon, Deborah Foster, R. Grimmett, Chloe Richardson, Alison Smith, P.W. |
| author_facet | Foster, Claire Breckons, Matthew Cotterell, P. Barbosa, D. Calman, Lynn Corner, Jessica Fenlon, Deborah Foster, R. Grimmett, Chloe Richardson, Alison Smith, P.W. |
| author_sort | Foster, Claire |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | PURPOSE
Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment.
METHODS
This cross-sectional online survey included cancer survivors who had completed their treatment within the past 12 months. Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support.
RESULTS
One hundred eighty-two respondents (mean age 50; 81 % female) completed the survey. They had been treated for a range of cancers; most commonly breast (45 %). Self-efficacy scores varied between individuals and according to the illness-related task to be managed. Respondents were least confident in managing fatigue and most confident in accessing information about their cancer. Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer.
CONCLUSIONS
Self-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment. Fatigue may be particularly difficult to manage.
IMPLICATIONS FOR CANCER SURVIVORS
Variations in self-efficacy highlight the importance of assessing specific problems faced and people's confidence to manage them in order to tailor appropriate self-management support. |
| first_indexed | 2025-11-14T19:15:43Z |
| format | Article |
| id | nottingham-32446 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:15:43Z |
| publishDate | 2014 |
| publisher | Springer |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-324462020-05-04T16:50:54Z https://eprints.nottingham.ac.uk/32446/ Cancer survivors’ self-efficacy to self-manage in the year following primary treatment Foster, Claire Breckons, Matthew Cotterell, P. Barbosa, D. Calman, Lynn Corner, Jessica Fenlon, Deborah Foster, R. Grimmett, Chloe Richardson, Alison Smith, P.W. BF Psychology RC 254 Neoplasms. Tumors. Oncology (including Cancer) PURPOSE Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment. METHODS This cross-sectional online survey included cancer survivors who had completed their treatment within the past 12 months. Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support. RESULTS One hundred eighty-two respondents (mean age 50; 81 % female) completed the survey. They had been treated for a range of cancers; most commonly breast (45 %). Self-efficacy scores varied between individuals and according to the illness-related task to be managed. Respondents were least confident in managing fatigue and most confident in accessing information about their cancer. Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer. CONCLUSIONS Self-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment. Fatigue may be particularly difficult to manage. IMPLICATIONS FOR CANCER SURVIVORS Variations in self-efficacy highlight the importance of assessing specific problems faced and people's confidence to manage them in order to tailor appropriate self-management support. Springer 2014-07-16 Article PeerReviewed Foster, Claire, Breckons, Matthew, Cotterell, P., Barbosa, D., Calman, Lynn, Corner, Jessica, Fenlon, Deborah, Foster, R., Grimmett, Chloe, Richardson, Alison and Smith, P.W. (2014) Cancer survivors’ self-efficacy to self-manage in the year following primary treatment. Journal of Cancer Survivorship, 9 (1). pp. 11-19. ISSN 1932-2267 self-management cancer survivors self-efficacy confidence neoplasms http://link.springer.com/article/10.1007%2Fs11764-014-0384-0 doi:10.1007/s11764-014-0384-0 doi:10.1007/s11764-014-0384-0 |
| spellingShingle | BF Psychology RC 254 Neoplasms. Tumors. Oncology (including Cancer) self-management cancer survivors self-efficacy confidence neoplasms Foster, Claire Breckons, Matthew Cotterell, P. Barbosa, D. Calman, Lynn Corner, Jessica Fenlon, Deborah Foster, R. Grimmett, Chloe Richardson, Alison Smith, P.W. Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title | Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title_full | Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title_fullStr | Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title_full_unstemmed | Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title_short | Cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| title_sort | cancer survivors’ self-efficacy to self-manage in the year following primary treatment |
| topic | BF Psychology RC 254 Neoplasms. Tumors. Oncology (including Cancer) self-management cancer survivors self-efficacy confidence neoplasms |
| url | https://eprints.nottingham.ac.uk/32446/ https://eprints.nottingham.ac.uk/32446/ https://eprints.nottingham.ac.uk/32446/ |